Supernus Pharmaceuticals (SUPN) Interest & Investment Income (2011 - 2026)
Supernus Pharmaceuticals' Interest & Investment Income came in at $2.63 million for Q2 2026, down 41.9% from $4.53 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Interest & Investment Income (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Supernus Pharmaceuticals reported Interest & Investment Income of $14.57 million, down 16.7% year-over-year; for FY2018, it was $13.84 million, up 383.3% from FY2017.
- Interest & Investment Income has increased in each of the last seven years, with a five-year compound annual growth rate of 115.3% (FY2013 to FY2018).
- Going back by year, Interest & Investment Income was $2.86 million in FY2017 (+95.2%), $1.47 million in FY2016 (+115.4%), $681,000 in FY2015 (+95.7%) and $348,000 in FY2014 (+16.4%).
- The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | 2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Sep 30, 2020 | 3.26 Mn |
| Jun 30, 2020 | 4.15 Mn |
| Sep 30, 2019 | 5.56 Mn |
| Jun 30, 2019 | 5.45 Mn |
| Mar 31, 2019 | 4.68 Mn |
| Dec 31, 2018 | 4.51 Mn |
| Sep 30, 2018 | 4.46 Mn |
| Jun 30, 2018 | 3.66 Mn |
| Mar 31, 2018 | 1.21 Mn |
| Dec 31, 2017 | 862,000.00 |
| Sep 30, 2017 | 814,000.00 |
| Jun 30, 2017 | 656,000.00 |
| Mar 31, 2017 | 531,000.00 |
| Dec 31, 2016 | 396,000.00 |
| Sep 30, 2016 | 378,000.00 |
| Jun 30, 2016 | 365,000.00 |
| Mar 31, 2016 | 327,000.00 |
| Dec 31, 2015 | 262,000.00 |
API Access
Supernus Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();